Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-04 Purchase | 2025-02-05 4:17 pm | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 50,000 | $10.69 | $534,500 | 1,172,674 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-03 Option Award | 2025-02-05 4:17 pm | N/A 2035-02-03 | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 243,000 | $0 | 1,172,674 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-17 8:07 pm | N/A N/A | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 5,205,750 | $0 | 879,674 (Direct) | View |
| 2024-09-12 Option Award | 2024-09-13 5:06 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 120,436 | $0 | 120,436 (Direct) | View |
Ownership | 2024-09-12 7:34 pm | N/A N/A | MBX Biosciences Inc. | MBX | Hawryluk P. Kent President & CEO | 0 | $0 | 1,910,632 (Direct) | View |